TransMedics Group, Inc. (TMDX)
70.74
-1.32
(-1.83%)
USD |
NASDAQ |
Oct 23, 16:00
70.60
-0.14
(-0.20%)
After-Hours: 20:00
TransMedics Group Enterprise Value : 2.845B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.845B |
| October 22, 2026 | 2.890B |
| October 21, 2026 | 2.902B |
| October 20, 2026 | 2.984B |
| October 19, 2026 | 2.875B |
| October 16, 2026 | 2.846B |
| October 15, 2026 | 3.045B |
| October 14, 2026 | 3.010B |
| October 13, 2026 | 3.135B |
| October 12, 2026 | 3.102B |
| October 09, 2026 | 3.092B |
| October 08, 2026 | 3.131B |
| October 07, 2026 | 3.202B |
| October 06, 2026 | 3.175B |
| October 05, 2026 | 3.269B |
| October 02, 2026 | 3.158B |
| October 01, 2026 | 3.118B |
| September 30, 2026 | 3.285B |
| September 29, 2026 | 3.306B |
| September 28, 2026 | 3.260B |
| September 25, 2026 | 3.349B |
| September 24, 2026 | 3.300B |
| September 23, 2026 | 3.408B |
| September 22, 2026 | 3.445B |
| September 21, 2026 | 3.418B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.388B |
| September 17, 2026 | 3.396B |
| September 16, 2026 | 3.427B |
| September 15, 2026 | 3.446B |
| September 14, 2026 | 3.368B |
| September 11, 2026 | 3.241B |
| September 10, 2026 | 3.340B |
| September 09, 2026 | 3.387B |
| September 08, 2026 | 3.452B |
| September 04, 2026 | 3.511B |
| September 03, 2026 | 3.407B |
| September 02, 2026 | 3.314B |
| September 01, 2026 | 3.243B |
| August 31, 2026 | 3.334B |
| August 28, 2026 | 3.457B |
| August 27, 2026 | 3.572B |
| August 26, 2026 | 3.589B |
| August 25, 2026 | 3.636B |
| August 24, 2026 | 3.636B |
| August 21, 2026 | 3.677B |
| August 20, 2026 | 3.541B |
| August 19, 2026 | 3.649B |
| August 18, 2026 | 3.536B |
| August 17, 2026 | 3.455B |
| August 14, 2026 | 3.463B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 78.32B |
| Abbott Laboratories | 207.10B |
| Alphatec Holdings, Inc. | 2.205B |
| Baxter International, Inc. | 19.76B |
| Becton, Dickinson & Co. | 70.12B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 14.68M |
| Revenue (Quarterly) | 189.95M |
| Total Expenses (Quarterly) | 175.27M |
| EPS Diluted (Quarterly) | 0.4057 |
| Gross Profit Margin (Quarterly) | 57.34% |
| Profit Margin (Quarterly) | 7.73% |
| Earnings Yield | 5.43% |
| Operating Earnings Yield | 2.91% |
| Normalized Earnings Yield | 5.434 |